Inherited gene variation leaves young leukemia patients at risk for peripheral neuropathy
Tuesday, February 24, 2015 - 13:30
in Health & Medicine
Researchers have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used anti-cancer drug. Investigators also found evidence of how it may be possible to protect young leukemia patients without jeopardizing cures.